Skip to content
Clinical Trials – home
Fundacio Hospital Universitari Vall D’Hebron Institut De Recerca
Sponsor

Fundacio Hospital Universitari Vall D’Hebron Institut De Recerca

Spain Passeig De La Vall D'Hebron 119-129, 08035 Barcelona, Spain

About the sponsor

Kidney transplantation, renal graft failure, and solid organ transplantation are central areas of interest, with studies addressing HLA sensitization, immunosuppressive therapy, and Epstein-Barr virus replication in transplant recipients. The sponsor also funds work in hyperimmunized patients and transplant-associated viral control.

  • Kidney transplantation
  • HLA sensitization
  • Epstein-Barr virus
  • Solid organ transplantation
  • Immunosuppressive therapy

These activities reflect a strong focus on post-transplant immune management and infection-related complications in transplant medicine.

About Specializations

Fundacio Hospital Universitari Vall D’Hebron Institut De Recerca runs clinical trials in conditions such as Renal transplant, Type 2 diabetes mellitus, Bacterial infection, Migraine, among others.

Recruiting now

Ongoing trials

Clinical trials run by this sponsor – those enrolling participants first.

Condition
Country
City
Type of trial
Recruitment status
Quick filters

19 clinical trials

Registered drug
Countries:SpainSpain
  • Participants:0–17 years · 18–64 years
  • Substances:Amikacin
  • Sponsor:Fundacio Hospital Universitari Vall D’Hebron Institut De Recerca

Migraine

Recruiting
Registered drug
Countries:SpainSpain
  • Participants:18–64 years
  • Substances:Isosorbide Dinitrate
  • Sponsor:Fundacio Hospital Universitari Vall D’Hebron Institut De Recerca
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Camellia Sinensis (Green Tea) Leaf Extract
  • Sponsor:Fundacio Hospital Universitari Vall D’Hebron Institut De Recerca
Countries:The NetherlandsThe Netherlands
  • Participants:18–64 years · 65+ years
  • Substances:Isoniazid
  • Sponsor:Fundacio Hospital Universitari Vall D’Hebron Institut De Recerca
Registered drug
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Ivermectin
  • Sponsor:Fundacio Hospital Universitari Vall D’Hebron Institut De Recerca
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Cefixime
  • Sponsor:Fundacio Hospital Universitari Vall D’Hebron Institut De Recerca
Countries:SpainSpain
  • Participants:0–17 years · 18–64 years
  • Substances:Irinotecan
  • Sponsor:Fundacio Hospital Universitari Vall D’Hebron Institut De Recerca
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Indocyanine Green
  • Sponsor:Fundacio Hospital Universitari Vall D’Hebron Institut De Recerca
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Ciclosporin
  • Sponsor:Fundacio Hospital Universitari Vall D’Hebron Institut De Recerca

Type 2 diabetes mellitus

Not yet recruiting
Registered drug
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Semaglutide
  • Sponsor:Fundacio Hospital Universitari Vall D’Hebron Institut De Recerca
Registered drug
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Maribavir
  • Sponsor:Fundacio Hospital Universitari Vall D’Hebron Institut De Recerca

Pre-eclampsia

Not yet recruiting
Registered drug
Countries:SpainSpain
  • Participants:18–64 years
  • Substances:Acetylsalicylic Acid
  • Sponsor:Fundacio Hospital Universitari Vall D’Hebron Institut De Recerca

Are you running a clinical trial?

Increase visibility for your trials and help patients find your site through our platform.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.

Legal notice · Published by CTIN POLAND sp. z o.o., ul. rtm. Witolda Pileckiego 67/109, 02-781 Warsaw, Poland · KRS 0001111334 · REGON 528919042 · NIP 9512598637

© 2026 Clinical Trials EU – European Clinical Trials Information Network

GDPR compliance, ISO 9001 and ISO 27001 certified (LL-C Certification)

On this site, “treatment” means an investigational medicine being studied in a clinical trial. Its safety and efficacy for the use being studied have not yet been confirmed, some participants may receive a placebo or a comparator medicine, and taking part does not guarantee any health benefit. The decision to take part is made by the doctor at the research site. This site is for information only and does not replace medical advice.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic sites, national regulators and commercial sponsors. On this site, “treatment” and “therapy” mean a medicine being tested in a clinical trial. Its safety and effectiveness in the use being studied are not yet confirmed, some participants may receive a placebo or a comparator, and taking part does not guarantee a health benefit. The doctor at the research site decides who can take part. This site provides information, not medical advice. Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).